We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

176 hedge funds and large institutions have $304M invested in Esperion Therapeutics in 2024 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more call options, than puts

Call options by funds: $7.09M | Put options by funds: $3.5M

92% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 26

87% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 30

15% more funds holding

Funds holding: 153176 (+23)

4.52% more ownership

Funds ownership: 67.81%72.33% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

10% less capital invested

Capital invested by funds: $336M → $304M (-$32M)

Holders
176
Holders Change
+23
Holders Change %
+15.03%
% of All Funds
2.54%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
56
Increased
50
Reduced
26
Closed
30
Calls
$7.09M
Puts
$3.5M
Net Calls
+$3.59M
Net Calls Change
-$1.14M
Name Holding Trade Value Shares
Change
Change in
Stake
NRD
201
Nebula Research & Development
New York
-$37.5K -13,974 Closed
CH
202
CVI Holdings
Delaware
-$36.8K -13,734 Closed
Macquarie Group
203
Macquarie Group
Australia
-$25 -9,215 Closed
First Manhattan
204
First Manhattan
New York
-$2.68K -1,000 Closed
AssetMark Inc
205
AssetMark Inc
California
-$21 -8 Closed
EC
206
Elequin Capital
New York
-$3 -1 Closed